Completed
Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications
NCT05104723
- Conditions
- Chronic Disease, Chronic Granulomatous Disease, Colitis, +26 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States